Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CCCS
|
Rodney Christo
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 65,084 Reduced 100.0% |
$814,851
$12.52 p/Share
|
Nov 22
2024 |
CCCS
|
Rodney Christo
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 65,084 Added 50.0% |
$162,710
$2.5 p/Share
|
Nov 22
2024 |
CORT
|
Gary Charles Robb
Chief Business Officer |
SELL
Bona fide gift
|
Direct | 300 Reduced 1.49% |
-
|
Nov 22
2024 |
CORT
|
Gary Charles Robb
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 2,609 Reduced 11.46% |
$146,625
$56.2 p/Share
|
Nov 22
2024 |
ALKT
|
Stephen Bohanon
Chief Strategy & Product Offr. |
SELL
Open market or private sale
|
Direct | 64,605 Reduced 14.74% |
$2,632,653
$40.75 p/Share
|
Nov 22
2024 |
ALKT
|
Stephen Bohanon
Chief Strategy & Product Offr. |
BUY
Exercise of conversion of derivative security
|
Direct | 62,043 Added 12.4% |
$959,184
$15.46 p/Share
|
Nov 22
2024 |
CCCS
|
Mary Jo Prigge
Officer |
SELL
Open market or private sale
|
Direct | 80,724 Reduced 45.35% |
$1,010,664
$12.52 p/Share
|
Nov 22
2024 |
CCCS
|
Mary Jo Prigge
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 80,724 Added 31.2% |
$201,810
$2.5 p/Share
|
Nov 22
2024 |
CORT
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct | 1,411 Reduced 14.25% |
$80,031
$56.72 p/Share
|
Nov 22
2024 |
TUSK
|
Corey J. Booker
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.65% |
$34,300
$3.43 p/Share
|
Nov 22
2024 |
AFRM
|
Michael Linford
Chief Operating Officer |
SELL
Bona fide gift
|
Direct | 47,842 Reduced 36.26% |
-
|
Nov 22
2024 |
AFRM
|
Libor Michalek
President |
SELL
Open market or private sale
|
Direct | 100,821 Reduced 38.74% |
$6,960,681
$69.04 p/Share
|
Nov 22
2024 |
AFRM
|
Libor Michalek
President |
BUY
Exercise of conversion of derivative security
|
Direct | 100,821 Added 27.92% |
$887,224
$8.8 p/Share
|
Nov 22
2024 |
DIBS
|
Matthew Rubinger
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 12,002 Reduced 49.03% |
$47,287
$3.94 p/Share
|
Nov 22
2024 |
KKR
|
Joseph Y Bae
Co-Chief Executive Officer |
BUY
Bona fide gift
|
Indirect | 1,069,162 Added 0.0% |
-
|
Nov 22
2024 |
KKR
|
Joseph Y Bae
Co-Chief Executive Officer |
SELL
Bona fide gift
|
Indirect | 1,069,162 Reduced 0.0% |
-
|
Nov 22
2024 |
CRVL
|
V Gordon Clemons
Chairman of the Board |
SELL
Open market or private sale
|
Indirect | 7,200 Reduced 0.0% |
$2,644,632
$367.31 p/Share
|
Nov 22
2024 |
UAN
|
Icahn Carl C
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,500 Added 0.0% |
$180,900
$72.36 p/Share
|
Nov 22
2024 |
RJF
|
Paul C Reilly
Chair & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,750 Added 1.47% |
-
|
Nov 22
2024 |
RJF
|
Paul C Reilly
Chair & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,387 Reduced 0.55% |
$227,162
$163.78 p/Share
|
Nov 22
2024 |
RJF
|
Christopher S Aisenbrey
Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 900 Added 8.08% |
-
|
Nov 22
2024 |
RJF
|
Christopher S Aisenbrey
Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 219 Reduced 2.14% |
$35,867
$163.78 p/Share
|
Nov 22
2024 |
DDOG
|
Olivier Pomel
Chief Executive Officer |
SELL
Bona fide gift
|
Direct | 438,000 Reduced 52.72% |
-
|
Nov 22
2024 |
DDOG
|
Olivier Pomel
Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct | 438,000 Added 34.52% |
-
|
Nov 22
2024 |
CLAQW
|
William Flores
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 16.35% |
$1,040
$1.04 p/Share
|
Nov 22
2024 |
RJF
|
Shannon B Reid
President, ICD |
BUY
Exercise of conversion of derivative security
|
Direct | 375 Added 4.62% |
-
|
Nov 22
2024 |
RJF
|
Shannon B Reid
President, ICD |
SELL
Payment of exercise price or tax liability
|
Direct | 91 Reduced 1.17% |
$14,903
$163.78 p/Share
|
Nov 22
2024 |
SLG
|
Andrew S Levine
CHIEF LEGAL OFFICER & GC |
BUY
Conversion of derivative security
|
Direct | 45,785 Added 45.94% |
-
|
Nov 22
2024 |
IIIV
|
Gregory S Daily
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 48,544 Added 50.0% |
$1,141,269
$23.51 p/Share
|
Nov 22
2024 |
FTAI
|
Paul R Goodwin
Director |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.0% |
$3,487,200
$174.36 p/Share
|
Nov 22
2024 |
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 9,062 Reduced 0.08% |
$3,111,165
$343.32 p/Share
|
Nov 22
2024 |
RGS
|
Kersten Delores Zupfer
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,400 Added 31.77% |
-
|
Nov 22
2024 |
AGM
|
Chester J Culver
Director |
SELL
Open market or private sale
|
Direct | 374 Reduced 13.85% |
$76,307
$204.03 p/Share
|
Nov 22
2024 |
RGS
|
John C. Davi
EVP, Chief Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,400 Added 44.06% |
-
|
Nov 22
2024 |
RGS
|
James Raymon Suarez
EVP Merchandising & Education |
BUY
Grant, award, or other acquisition
|
Direct | 5,400 Added 38.61% |
-
|
Nov 22
2024 |
PX
|
Edwin A. Poston |
SELL
Open market or private sale
|
Direct | 54,103 Reduced 100.0% |
$737,423
$13.63 p/Share
|
Nov 22
2024 |
RGS
|
Jim Brian Lain
EVP, Brand Operations |
BUY
Grant, award, or other acquisition
|
Direct | 5,400 Added 37.02% |
-
|
Nov 22
2024 |
NRDY
|
Charles K. Cohn
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 421,796 Added 0.0% |
$590,514
$1.4 p/Share
|
Nov 22
2024 |
NXST
|
Perry A Sook
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 46,940 Reduced 6.5% |
$7,979,800
$170.0 p/Share
|
Nov 22
2024 |
NXST
|
Perry A Sook
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 46,940 Added 6.11% |
$2,211,343
$47.11 p/Share
|
Nov 22
2024 |
GSBD
|
John Lanza |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 100.0% |
$16,062
$12.85 p/Share
|
Nov 22
2024 |
RGS
|
Michelle St. Lawrence De Vore
SVP, Marketing |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 50.0% |
-
|
Nov 22
2024 |
RGS
|
Michael Heath Ferranti
EVP Brand Operations |
BUY
Grant, award, or other acquisition
|
Direct | 5,400 Added 39.64% |
-
|
Nov 22
2024 |
RGS
|
Matthew Doctor
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 16,500 Added 45.73% |
-
|
Nov 22
2024 |
EVCM
|
Ryan H Siurek
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,396 Reduced 1.06% |
$16,570
$11.87 p/Share
|
Nov 22
2024 |
EVCM
|
Eric Richard Remer
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 13,772 Reduced 1.13% |
$163,473
$11.87 p/Share
|
Nov 22
2024 |
DNLI
|
Alexander O. Schuth
COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 20,516 Added 9.36% |
$13,950
$0.68 p/Share
|
Nov 22
2024 |
HNRG
|
David C Hardie
Director |
SELL
Open market or private sale
|
Indirect | 33,308 Reduced 0.0% |
$434,669
$13.05 p/Share
|
Nov 22
2024 |
ALL
|
Thomas J Wilson
Chairman, President & CEO |
SELL
Open market or private sale
|
Indirect | 31,503 Reduced 0.0% |
$6,418,736
$203.75 p/Share
|
Nov 22
2024 |
ALL
|
Thomas J Wilson
Chairman, President & CEO |
BUY
Bona fide gift
|
Indirect | 43,022 Added 0.0% |
-
|
Nov 22
2024 |